These emerging medications , Tirzepatide , represent a groundbreaking advancement in treating type 2 diabetes and potentially related ailments . They all are categorized as GLP-1 pathway activators , meaning these substances to mimic the endogenous GLP-1 peptide, boosting glucose release and lowe